The Rate of Adverse Events Related to Hypnosis During Clinical Trials

The American Journal of Clinical Hypnosis
Jared W Bollinger

Abstract

The rate of adverse events associated with medical and psychological interventions is important to regulators who oversee clinical research. There have been relatively few reports on the frequency of adverse events associated with hypnosis. The current article collected data from a publically available register (ClinicalTrials.gov) on adverse events reported during clinical trials that used hypnosis. The rate of serious adverse events likely attributable to hypnosis was 0%. The rate of other adverse events was 0.47%. This rate was similar to previous reports. However, several trials in the register that used hypnosis did not report adverse event data. For the trials that did report adverse events, there was substantial variability in reporting. Another limitation was the lack of generalizability as all studies included in the analysis used hypnosis to treat side-effects related to medical conditions or procedures as opposed to psychiatric conditions. Future clinical trials using hypnosis should use more precise assessment methods to report adverse events, especially when tested in samples with mental health disorders.

References

Nov 1, 1992·Journal of Abnormal Psychology·H J CrawfordB Olesko
Oct 1, 1974·The International Journal of Clinical and Experimental Hypnosis·J R Hilgard
Jan 1, 1971·The International Journal of Clinical and Experimental Hypnosis·J G Watkins
Apr 1, 1982·The International Journal of Clinical and Experimental Hypnosis·H J CrawfordH Macdonald
Apr 1, 1981·The International Journal of Clinical and Experimental Hypnosis·M Kleinhauz, B Beran
Jul 1, 1993·The American Journal of Clinical Hypnosis·R A Page, G W Handley
Jul 1, 1995·The American Journal of Clinical Hypnosis·W C CoeM Gwynn
Jan 1, 1996·The International Journal of Clinical and Experimental Hypnosis·S J LynnD C Frauman
Oct 1, 1962·The American Journal of Clinical Hypnosis·A M WEITZENHOFFER
Feb 24, 2009·The International Journal of Clinical and Experimental Hypnosis·Etzel Cardeña, Devin B Terhune
Mar 2, 2010·The American Journal of Clinical Hypnosis·Harold J Wain, Jason Dailey
Oct 12, 2010·The Cochrane Database of Systematic Reviews·Jo BarnesLindsay F Stead
Mar 4, 2011·The New England Journal of Medicine·Deborah A ZarinNicholas C Ide
Nov 30, 2012·The American Journal of Clinical Hypnosis·Richard P Kluft
Oct 3, 2014·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Michael Linden, Marie-Luise Schermuly-Haupt
Sep 15, 2015·Complementary Therapies in Medicine·Tak-Ho LamTommy Ho-Yee Ng
May 14, 2016·Deutsches Ärzteblatt International·Winfried HäuserErnil Hansen
May 20, 2016·The Cochrane Database of Systematic Reviews·Kelly MaddenLeanne Jones

❮ Previous
Next ❯

Citations

Jun 26, 2018·Journal of Psychopharmacology·Clément E Lemercier, Devin B Terhune
Mar 17, 2021·Clinical Psychology Review·Mareike HollerJenny Rosendahl

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Clinical Trials Mentioned

NCT00122369
NCT00293293
NCT00361270
NCT01248013
NCT00793611
NCT01293695
NCT00711529

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Neurologia, neurochirurgia i psychiatria polska
H SZYDLIK
Journal of the American Medical Association
Singapore Medical Journal
T M Chong
© 2022 Meta ULC. All rights reserved